New progress in the study of retinitis pigmentosa
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81770948); Fujian Provincial Science and Technology Innovation Leadership Talent Foundation(No.2016B011)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Retinitis pigmentosa(RP)was known as pigmentation retinitis even. RP is a group of hereditary eye diseases that cause irreversible visual impairment due to progressive loss of function of retinal pigment epithelial cells and progressive apoptosis of photoreceptors. Because of its heterogeneity in phenotype and heredity and complex pathogenesis, there is currently no single effective treatment. This article mainly elaborates on the progress in the treatment of retinitis pigmentosa in recent years.

    Reference
    Related
    Cited by
Get Citation

Yue Wang, Guo-Xing Xu. New progress in the study of retinitis pigmentosa. Guoji Yanke Zazhi( Int Eye Sci) 2020;20(4):628-630

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:May 16,2019
  • Revised:February 27,2020
  • Adopted:
  • Online: March 25,2020
  • Published: